Surface Oncology Inc SURF:NASDAQ

Last Price$1.92NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/20/22

Today's Change-0.05(2.54%)
Bid (Size)$1.85 (3)
Ask (Size)$1.92 (17)
Day Low / High$1.83 - 2.04
Volume504.9 K

Surface Oncology Gets US FDA Clearance for Human Clinical Trial of Potential Anti-Tumor Therapy

8:39AM ET 12/01/2021 MT Newswires
Surface Oncology (SURF) said Wednesday the US Food and Drug Administration has cleared the company's investigational new drug application for its GSK4381562, a fully human IgG1 antibody, to proceed to a first-in-human clinical trial.

The investigational antibody promotes the activation of both natural killer cells and T cells, with the potential to elicit a strong anti-tumor response and promote immunological memory, according to a statement.

Surface Oncology will receive a $30 million milestone payment at the start of the first phase 1 study for GSK4381562. The company is also eligible to receive an additional $700 million in future milestone payments, as well as tiered royalties on global net sales.

Price: 5.89, Change: +0.12, Percent Change: +0.02